Protara Therapeutics, Inc. TARA
NASDAQ · United States · Health Technology
$2.64-0.13 (-4.53%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.36 | -0.33 | -10.5% | $0 | — | -5.4%$4.11→$3.89 |
| Q1 2026 | 2026-05-13 | -0.31 | -0.37 | +16.2% | — | — | +2.9%$5.15→$5.30 |
| Q4 2025 | 2026-03-10 | -0.38 | -0.31 | -22.6% | — | — | -2.6%$5.75→$5.60 |
| Q3 2025 | 2025-11-10 | -0.31 | -0.39 | +20.5% | — | — | +24.9%$4.29→$5.36 |
| Q2 2025 | 2025-08-11 | -0.35 | -0.41 | +14.6% | — | — | — |
| Q4 2024 | 2025-03-05 | -0.43 | -0.56 | +23.2% | — | — | — |
| Q4 2023 | 2024-03-13 | -0.90 | -0.92 | +2.2% | — | — | — |
| Q3 2023 | 2023-11-03 | -0.87 | -0.98 | +11.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.